Topological insulator bismuth selenide as a theranostic platform for simultaneous cancer imaging and therapy

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Li, Juan ^a   Jiang, Fei ^b   Yang, Bo ^b   Song, Xiao Rong ^a   Liu, Yan ^c   Yang, Huang Hao ^a   Cao, Dai Rong ^b   Shi, Wen Rong ^c   Chen, Guo Nan ^a  

^a FUZHOU UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

^c FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH; DIAGNOSTIC AGENT; SELENIUM;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; EXPERIMENTAL NEOPLASM; FEMALE; MOUSE; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; DIAGNOSTIC USE; NEOPLASMS, EXPERIMENTAL;

ANIMALS; BISMUTH; FEMALE; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, TRANSMISSION; NEOPLASMS, EXPERIMENTAL; SELENIUM; TOMOGRAPHY, X-RAY COMPUTED; X-RAY DIFFRACTION;

EID: 84879615495     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01998     Document Type: Article

References (54)

1. Cancer [homepage on the Internet]. Geneva: World Health Organization. Accessed January 15, 2013. Available from: http://www.who.int/cancer/about/ facts/en/.
2. Funkhouser, J. Reinventing pharma: the theranostic revolution. Curr. Drug Discovery 2, 17-19 (2002). (Pubitemid 34919080)
3. Bardhan, R., Lal, S., Joshi, A. & Halas, N. J. Theranostic nanoshells: from probe design to imaging and treatment of cancer. Acc. Chem. Res. 44, 936-946 (2011).
4. Davis, M. E., Chen, Z. G. & Shin, D. M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discovery 7, 771-782 (2008).
5. Petros, R. A. & DeSimone, J. M. Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discovery 9, 615-627 (2010).
6. Dong, H. F. et al. Target-cell-specific delivery, imaging, and detection of intracellular microRNA with a multifunctional SnO2 nanoprobe. Angew. Chem. Int. Ed. 51, 4607-4612 (2012).
7. Lee, D. E. et al. Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem. Soc. Rev. 41, 2656-2672 (2012).
8. Xie, J., Liu, G., Eden, H. S., Ai, H. & Chen, X. Y. Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy. Acc. Chem. Res. 44, 883-892 (2011).
9. Chen, T. et al. Smart multifunctional nanostructure for targeted cancer chemotherapy and magnetic resonance imaging. ACS Nano 5, 7866-7873 (2011).
10. Reddy, L. H., Arias, J. L.,Nicolas, J. & Couvreur, P. Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem. Rev. 112, 5818-5878 (2012).
11. Kostarelos, K., Bianco, A. & Prato, M. Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat. Nanotechnol. 4, 627-633 (2009).
12. Kam, N. W. S., Connell, M. O., Wisdom, J. A. & Dai, H. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc. Natl Acad. Sci. USA 102, 11600-11605 (2005). (Pubitemid 41170772)
13. Xia, Y. N. et al. Gold nanocages: from synthesis to theranostic applications. Acc. Chem. Res. 44, 914-924 (2011).
14. Huang, X. H., Neretina, S. & El-Sayed, M. A. Gold nanorods: from synthesis and properties to biological and biomedical applications. Adv. Mater. 21, 4880-4910 (2009).
15. Ke, H. T. et al. Gold-nanoshelled microcapsules: a theranostic agent for ultrasound contrast imaging and photothermal therapy. Angew. Chem. Int. Ed. 50, 3017-3021 (2011).
16. Hirsch, L. R. et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl Acad. Sci. USA 100, 13549-13554 (2003). (Pubitemid 37444779)
17. Chen, Y. L. et al. Experimental realization of a three-dimensional topological insulator, Bi2Te3. Science 325, 178-181 (2009).
18. Kong, D. S. & Cui, Y. Opportunities in chemistry and materials science for topological insulators and their nanostructures. Nat. Chem. 3, 845-849 (2011).
19. Xia, Y. et al. Observation of a large-gap topological-insulator class with a single Dirac cone on the surface. Nat. Phys. 5, 398-402 (2009).
20. Hor, Y. S. et al. p-type Bi2Se3 for topological insulator and low-temperature thermoelectric applications. Phys. Rev. B 79, 195208 (2009).
21. LaForge, A. D. et al.Optical characterization of Bi2Se3 in amagnetic field: Infrared evidence for magnetoelectric coupling in a topological insulator material. Phys. Rev. B 81, 125120 (2010).
22. Yu, Y., Sun, W. T.,Hu, Z. D., Chen, Q. & Peng, L. M. Oriented Bi2Se3 nanoribbons film: structure, growth, and photoelectric properties. Mater. Chem. Phys. 124, 865-869 (2010).
23. Sun, H. Z., Li, H. Y., Harvey, I. & Sadler, P. J. Interactions of bismuth complexes with metallothionein(II). J. Biol. Chem. 274, 29094-29101 (1999).
24. Briand, G. G.& Burford, N. Bismuth compounds and preparations with biological or medicinal relevance. Chem. Rev. 99, 2601-2657 (1999).
25. Rabin, O., Perez, J. M., Grimm, J., Wojtkiewicz, G. & Weissleder, R. An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat. Mater. 5, 118-122 (2006). (Pubitemid 43177900)
26. Kinsella, J. M. et al. X-ray computed tomography imaging of breast cancer by using targeted peptide-labeled bismuth sulfide nanoparticles. Angew. Chem. Int. Ed. 50, 12308-12311 (2011).
27. Ai, K. L. et al. Large-scale synthesis of Bi2S3 nanodots as a contrast agent for in vivo X-ray computed tomography imaging. Adv. Mater. 23, 4886-4891 (2011).
28. Whanger, P. D. Selenium and its relationship to cancer: an update. Br. J. Nutr. 91, 11-28 (2004). (Pubitemid 38100556)
29. Rayman, M. P. The importance of selenium to human health. Lancet 356, 233-241 (2000). (Pubitemid 30446984)
30. Rayman, M. P. Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc. Nutr. Soc. 64, 527-542 (2005). (Pubitemid 41705454)
31. Min, Y. et al. Quick, controlled synthesis of ultrathin Bi2Se3 nanodiscs and nanoplates. J. Am. Chem. Soc. 134, 2872-2875 (2012).
32. Buhler, V. KollidonH Polyvinylpyrrolidone for the Pharmaceutical Industry 9-125 (BASF Fine Chemicals, Ludwigshafen, 1998).
33. Sun, Y. G.& Xia, Y. N. Shape-controlled synthesis of gold and silver nanoparticles. Science 298, 2176-2179 (2002).
34. Lu, G. et al. Imparting functionality to a metal-organic framework material by controlled nanoparticle encapsulation. Nat. Chem. 4, 310-316 (2012).
35. Silverstein, S. C., Steinman, R.M. & Cohn, Z. A. Endocytosis. Annu. Rev. Biochem. 46, 669-722 (1977).
36. Dreaden, E. C., Mackey, M. A.,Huang, X. H., Kangy, B. & El-Sayed, M. A. Beating cancer in multiple ways using nanogold. Chem. Soc. Rev. 40, 3391-3404 (2011).
37. Welsher, K. et al. A route to brightly fluorescent carbon nanotubes for near infrared imaging in mice. Nat. Nanotechnol. 4, 773-780 (2009).
38. Yang, K. et al. In vitro and in vivo near-infrared photothermal therapy of cancer using polypyrrole organic nanoparticles. Adv. Mater. 24, 5586-5592 (2012).
39. Zha, Z., Yue, X., Ren, Q. & Dai, Z. Uniform polypyrrole nanoparticles with high photothermal conversion efficiency for photothermal ablation of cancer cells. Adv. Mater. 25, 777-782 (2013).
40. Cheng, L., Yang, K., Chen, Q. & Liu, Z. Organic stealth nanoparticles for highly effective in vivo near-infrared photothermal therapy of cancer. ACS Nano 6, 5605-5613 (2012).
41. Yang, J. et al. Convertible organic nanoparticles for near-infrared photothermal ablation of cancer cells. Angew. Chem. Int. Ed. 50, 441-444 (2011).
42. Moon, H. K., Lee, S. H. & Choi, H. C. In vivo near-infrared mediated tumor destruction by photothermal effect of carbon nanotubes. ACS Nano 3, 3707-3713 (2009).
43. Ghosh, S. et al. Increased heating efficiency and selective thermal ablation of malignant tissue with DNA-encased multiwalled carbon nanotubes. ACS Nano 3, 2667-2673 (2009).
44. Robinson, J. T. et al. High performance in vivo near-IR (.1 mm) imaging and photothermal cancer therapy with carbon nanotubes. Nano Res. 3, 779-793 (2010).
45. Liu, X. et al.Optimization of surface chemistry on single-walled carbon nanotubes for in vivo photothermal ablation of tumors. Biomaterials, 32, 144-151 (2011).
46. Robinson, J. T. et al. Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. J. Am. Chem. Soc. 133, 6825-6831 (2011).
47. Yang, K. et al. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett. 10, 3318-3323 (2010).
48. Yang, K. et al. The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. Biomaterials, 33, 2206-2214 (2012).
49. Huang, X. Q. et al. Freestanding palladium nanosheets with plasmonic and catalytic properties. Nat. Nanotechnol. 6, 28-32 (2011).
50. Chou, S. S. et al. Chemically exfoliated MoS2 as near-infrared photothermal agents. Angew. Chem. Int. Ed. 52, 4160-4164 (2013).
51. Zhou, M. et al. A chelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy. J. Am. Chem. Soc. 132, 15351-15358 (2010).
52. Tian, Q. et al. Hydrophilic flower-like CuS superstructures as an efficient 980 nm laser-driven photothermal agent for ablation of cancer cells. Adv. Mater. 23, 3542-3547 (2011).
53. Tian, Q. et al.Hydrophilic Cu9S5 nanocrystals: Aphotothermal agent with a 25.7% heat conversion efficiency for photothermal ablation of cancer cells in vivo. ACS Nano 5, 9761-9771 (2011).
54. Hessel, C. M. et al. Copper selenide nanocrystals for photothermal therapy. Nano Lett. 11, 2560-2566 (2011).